{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:43:15Z","timestamp":1794008595464,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Shandong Provincial Natural Science Foundation, China","award":["No. ZR2023MH230, ZR2023MH096"],"award-info":[{"award-number":["No. ZR2023MH230, ZR2023MH096"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04359-5","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T10:53:29Z","timestamp":1775300009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dual-loaded homotypic exosomes with endogenous IR808 and pH-responsive DOX drive sequenced chemo-PDT and convert \u201ccold\u201d OSCC tumors \u201chot\u201d"],"prefix":"10.1186","volume":"24","author":[{"given":"He","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baihui","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoding","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"4359_CR1","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1038\/s41467-022-33080-8","volume":"13","author":"W-T Ju","year":"2022","unstructured":"Ju W-T, Xia R-H, Zhu D-W, Dou S-J, Zhu G-P, Dong M-J, Wang L-Z, Sun Q, Zhao T-C, Zhou Z-H, et al. A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nat Commun. 2022;13:5378.","journal-title":"Nat Commun"},{"key":"4359_CR2","doi-asserted-by":"publisher","first-page":"217482","DOI":"10.1016\/j.canlet.2025.217482","volume":"614","author":"C-S Wu","year":"2025","unstructured":"Wu C-S, Li H-P, Hsieh C-H, Lin Y-T, Yi-Feng Chang I, Chung A-K, Huang Y, Ueng S-H, Hsiao Y-C, Chien K-Y, et al. Integrated multi-omics analyses of oral squamous cell carcinoma reveal precision patient stratification and personalized treatment strategies. Cancer Lett. 2025;614:217482.","journal-title":"Cancer Lett"},{"key":"4359_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41551-021-00807-9","volume":"6","author":"D-W Zheng","year":"2021","unstructured":"Zheng D-W, Deng W-W, Song W-F, Wu C-C, Liu J, Hong S, Zhuang Z-N, Cheng H, Sun Z-J, Zhang X-Z. Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma. Nat Biomedical Eng. 2021;6:32\u201343.","journal-title":"Nat Biomedical Eng"},{"key":"4359_CR4","doi-asserted-by":"publisher","first-page":"e2406662","DOI":"10.1002\/adma.202406662","volume":"37","author":"H Yuan","year":"2024","unstructured":"Yuan H, Qiu C, Wang X, Wang P, Yi L, Peng X, Xu X, Huang W, Bai Y, Wei J, et al. Engineering Semiconducting Polymeric Nanoagonists Potentiate cGAS-STING Pathway Activation and Elicit Long Term Memory Against Recurrence in Breast Cancer. Adv Mater (Deerfield Beach Fla). 2024;37:e2406662.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"4359_CR5","doi-asserted-by":"publisher","first-page":"e202215467","DOI":"10.1002\/anie.202215467","volume":"62","author":"Y Wang","year":"2023","unstructured":"Wang Y, Gong F, Han Z, Lei H, Zhou Y, Cheng S, Yang X, Wang T, Wang L, Yang N, et al. Oxygen-Deficient Molybdenum Oxide Nanosensitizers for Ultrasound-Enhanced Cancer Metalloimmunotherapy. Angewandte Chemie (International Ed English). 2023;62:e202215467.","journal-title":"Angewandte Chemie (International Ed English)"},{"key":"4359_CR6","first-page":"e2206737","volume":"10","author":"M Yin","year":"2023","unstructured":"Yin M, Dong J, Sun C, Liu X, Liu Z, Liu L, Kuang Z, Zhang N, Xiao D, Zhou X, Deng H. Raddeanin A Enhances Mitochondrial DNA-cGAS\/STING Axis-Mediated Antitumor Immunity by Targeting Transactive Responsive DNA-Binding Protein 43. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2023;10:e2206737.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"4359_CR7","doi-asserted-by":"publisher","first-page":"114283","DOI":"10.1016\/j.jconrel.2025.114283","volume":"388","author":"A Zhang","year":"2025","unstructured":"Zhang A, Zheng J, Xu Y, Fu S, Du Q, Zhao C, Meng Y, Li M, Wang L, Wang S, et al. Targeting polyamine metabolism induces oxidative\/carbonyl stress to reinvigorate antitumor immunity in prostate cancer. J Controlled Release. 2025;388:114283.","journal-title":"J Controlled Release"},{"key":"4359_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Reviews Disease Primers. 2020;6:92.","journal-title":"Nat Reviews Disease Primers"},{"key":"4359_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s40168-024-01907-9","volume":"12","author":"J Zhou","year":"2024","unstructured":"Zhou J, Hu Z, Wang L, Hu Q, Chen Z, Lin T, Zhou R, Cai Y, Wu Z, Zhang Z, et al. Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma. Microbiome. 2024;12:193.","journal-title":"Microbiome"},{"key":"4359_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","volume":"52","author":"B Solomon","year":"2018","unstructured":"Solomon B, Young RJ, Rischin D. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. Sem Cancer Biol. 2018;52:228\u201340.","journal-title":"Sem Cancer Biol"},{"key":"4359_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","volume":"17","author":"X Li","year":"2020","unstructured":"Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Reviews Clin Oncol. 2020;17:657\u201374.","journal-title":"Nat Reviews Clin Oncol"},{"key":"4359_CR12","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1021\/acsnano.4c11024","volume":"19","author":"Y Wenbin Zhou","year":"2025","unstructured":"Wenbin Zhou Y, Gao X, Feng Y, Zhang C, Yang L, He F, Zhang X, Li, Li Q. Biomimetic nanoplatform integrates FRET-enhanced photodynamic therapy and chemotherapy for cascaded revitalization of the tumor immune microenvironment in OSCC. ACS Nano. 2025;19:4251\u201368.","journal-title":"ACS Nano"},{"key":"4359_CR13","doi-asserted-by":"publisher","first-page":"e2305668","DOI":"10.1002\/adma.202305668","volume":"35","author":"M Cui","year":"2023","unstructured":"Cui M, Tang D, Wang B, Zhang H, Liang G, Xiao H. Bioorthogonal Guided Activation of cGAS-STING by AIE Photosensitizer Nanoparticles for Targeted Tumor Therapy and Imaging. Adv Mater (Deerfield Beach Fla). 2023;35:e2305668.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"4359_CR14","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.7150\/thno.87363","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Staudinger JN, Mindt TL, Gasser G. Theranostics with photodynamic therapy for personalized medicine: to see and to treat. Theranostics. 2023;13:5501\u201344.","journal-title":"Theranostics"},{"key":"4359_CR15","doi-asserted-by":"publisher","first-page":"9054","DOI":"10.7150\/thno.62479","volume":"11","author":"P Sarbadhikary","year":"2021","unstructured":"Sarbadhikary P, George BP, Abrahamse H. Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer. Theranostics. 2021;11:9054\u201388.","journal-title":"Theranostics"},{"key":"4359_CR16","doi-asserted-by":"publisher","first-page":"121368","DOI":"10.1016\/j.biomaterials.2022.121368","volume":"281","author":"Y Yang","year":"2022","unstructured":"Yang Y, Chen F, Xu N, Yao Q, Wang R, Xie X, Zhang F, He Y, Shao D, Dong W-F, et al. Red-light-triggered self-destructive mesoporous silica nanoparticles for cascade-amplifying chemo-photodynamic therapy favoring antitumor immune responses. Biomaterials. 2022;281:121368.","journal-title":"Biomaterials"},{"key":"4359_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","volume":"23","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Liu S, Trachootham D, Huang P. Targeting ROS in cancer: rationale and strategies. Nat Rev Drug Discovery. 2024;23:583\u2013606.","journal-title":"Nat Rev Drug Discovery"},{"key":"4359_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397.","journal-title":"Nat Rev Cancer"},{"key":"4359_CR19","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1038\/s41467-025-59590-9","volume":"16","author":"Z Liu","year":"2025","unstructured":"Liu Z, Luan X, Lu Q, Qin S, Zeng F, Li Z, He B, Song Y. Reactive oxygen species responsive nanomotors for gene edited metabolic disruption and immunotherapy. Nat Commun. 2025;16:4708.","journal-title":"Nat Commun"},{"key":"4359_CR20","doi-asserted-by":"publisher","first-page":"122365","DOI":"10.1016\/j.biomaterials.2023.122365","volume":"302","author":"H Zhang","year":"2023","unstructured":"Zhang H, Shi C, Han F, Cai L, Ma H, Long S, Sun W, Du J, Fan J, Chen X, Peng X. Synchronized activating therapeutic nano-agent: Enhancement and tracing for hypoxia-induced chemotherapy. Biomaterials. 2023;302:122365.","journal-title":"Biomaterials"},{"key":"4359_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.bioactmat.2024.06.038","volume":"36","author":"X Hu","year":"2024","unstructured":"Hu X, Zhang M, Quan C, Ren S, Chen W, Wang J. ROS-responsive and triple-synergistic mitochondria-targeted polymer micelles for efficient induction of ICD in tumor therapeutics. Bioactive Mater. 2024;36:490\u2013507.","journal-title":"Bioactive Mater"},{"key":"4359_CR22","first-page":"e2307870","volume":"11","author":"X Zhu","year":"2024","unstructured":"Zhu X, Zheng W, Wang X, Li Z, Shen X, Chen Q, Lu Y, Chen K, Ai S, Zhu Y, et al. Enhanced Photodynamic Therapy Synergizing with Inhibition of Tumor Neutrophil Ferroptosis Boosts Anti-PD-1 Therapy of Gastric Cancer. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11:e2307870.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"4359_CR23","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.7150\/thno.33888","volume":"9","author":"DC Thang","year":"2019","unstructured":"Thang DC, Wang Z, Lu X, Xing B. Precise cell behaviors manipulation through light-responsive nano-regulators: recent advance and perspective. Theranostics. 2019;9:3308\u201340.","journal-title":"Theranostics"},{"key":"4359_CR24","doi-asserted-by":"crossref","unstructured":"Huis In \u2018t Veld RV, Heuts J, Ma S, Cruz LJ, Ossendorp FA, Jager MJ: Current Challenges and Opportunities of Photodynamic Therapy against Cancer. Pharmaceutics 2023, 15.","DOI":"10.3390\/pharmaceutics15020330"},{"key":"4359_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41392-025-02140-y","volume":"10","author":"Y Cai","year":"2025","unstructured":"Cai Y, Chai T, Nguyen W, Liu J, Xiao E, Ran X, Ran Y, Du D, Chen W, Chen X. Phototherapy in cancer treatment: strategies and challenges. Signal Transduct Target Therapy. 2025;10:115.","journal-title":"Signal Transduct Target Therapy"},{"key":"4359_CR26","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1021\/nn102055s","volume":"4","author":"X Huang","year":"2010","unstructured":"Huang X, Peng X, Wang Y, Wang Y, Shin DM, El-Sayed MA, Nie S. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano. 2010;4:5887\u201396.","journal-title":"ACS Nano"},{"key":"4359_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.actbio.2023.05.043","volume":"166","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang H, Chen X, Wu C, Ding K, Sun G, Luo Y, Xiang D. Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery. Acta Biomater. 2023;166:42\u201368.","journal-title":"Acta Biomater"},{"key":"4359_CR28","doi-asserted-by":"crossref","unstructured":"Adepu S, Ramakrishna S. Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules 2021;26(19):5905.","DOI":"10.3390\/molecules26195905"},{"key":"4359_CR29","doi-asserted-by":"publisher","first-page":"e1802896","DOI":"10.1002\/adma.201802896","volume":"31","author":"B Yang","year":"2018","unstructured":"Yang B, Chen Y, Shi J. Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms. Adv Mater (Deerfield Beach Fla). 2018;31:e1802896.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"4359_CR30","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Sci (New York NY) 2020;367(6478):eaau6977.","DOI":"10.1126\/science.aau6977"},{"key":"4359_CR31","doi-asserted-by":"publisher","first-page":"e2002054","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia Y, Rao L, Yao H, Wang Z, Ning P, Chen X. Engineering Macrophages for Cancer Immunotherapy and Drug Delivery. Adv Mater (Deerfield Beach Fla). 2020;32:e2002054.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"4359_CR32","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.7150\/thno.33183","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Bai L, Guo K, Jia Y, Zhang K, Liu Q, Wang P, Wang X. Focused ultrasound-augmented targeting delivery of nanosonosensitizers from homogenous exosomes for enhanced sonodynamic cancer therapy. Theranostics. 2019;9:5261\u201381.","journal-title":"Theranostics"},{"key":"4359_CR33","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","volume":"10","author":"T Yong","year":"2019","unstructured":"Yong T, Zhang X, Bie N, Zhang H, Zhang X, Li F, Hakeem A, Hu J, Gan L, Santos HA, Yang X. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun. 2019;10:3838.","journal-title":"Nat Commun"},{"key":"4359_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.7150\/thno.88061","volume":"14","author":"S Liu","year":"2024","unstructured":"Liu S, Xiao X, Zhang L, Wang J, Zhao W, Liu H, Liao R, Li Z, Xu M, Guo J, et al. Reprogramming Exosomes to Escape from Immune Surveillance for Mitochondrial Protection in Hepatic Ischemia-Reperfusion Injury. Theranostics. 2024;14:116\u201332.","journal-title":"Theranostics"},{"key":"4359_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","volume":"172","author":"SAA Kooijmans","year":"2013","unstructured":"Kooijmans SAA, Stremersch S, Braeckmans K, de Smedt SC, Hendrix A, Wood MJA, Schiffelers RM, Raemdonck K, Vader P. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Controlled Release: Official J Controlled Release Soc. 2013;172:229\u201338.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"4359_CR36","doi-asserted-by":"publisher","first-page":"2562224","DOI":"10.1080\/10717544.2025.2562224","volume":"32","author":"M Singh","year":"2025","unstructured":"Singh M, Mazaheri-Tehrani G, Martin-Fabiani I, Davies OG. Electroporation induced changes in extracellular vesicle profile. Drug Delivery. 2025;32:2562224.","journal-title":"Drug Delivery"},{"key":"4359_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","volume":"6","author":"D Ha","year":"2016","unstructured":"Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sinica B. 2016;6:287\u201396.","journal-title":"Acta Pharm Sinica B"},{"key":"4359_CR38","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications. Int J Nanomed. 2020;15:6917\u201334.","journal-title":"Int J Nanomed"},{"key":"4359_CR39","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1038\/s41467-025-59489-5","volume":"16","author":"G Son","year":"2025","unstructured":"Son G, Song J, Park JC, Kim HN, Kim H. Fusogenic lipid nanoparticles for rapid delivery of large therapeutic molecules to exosomes. Nat Commun. 2025;16:4799.","journal-title":"Nat Commun"},{"key":"4359_CR40","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.2147\/IJN.S444582","volume":"18","author":"J Tian","year":"2023","unstructured":"Tian J, Han Z, Song D, Peng Y, Xiong M, Chen Z, Duan S, Zhang L. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications. Int J Nanomed. 2023;18:7923\u201340.","journal-title":"Int J Nanomed"},{"key":"4359_CR41","doi-asserted-by":"crossref","unstructured":"Liao W, Du Y, Zhang C, Pan F, Yao Y, Zhang T, Peng Q. Exosomes: The next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater 2019;86:1-14.","DOI":"10.1016\/j.actbio.2018.12.045"},{"key":"4359_CR42","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","volume":"347","author":"I Kimiz-Gebologlu","year":"2022","unstructured":"Kimiz-Gebologlu I, Oncel SS. Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J Controlled Release: Official J Controlled Release Soc. 2022;347:533\u201343.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"4359_CR43","doi-asserted-by":"publisher","first-page":"33890","DOI":"10.1021\/acsami.3c05926","volume":"15","author":"Z Hu","year":"2023","unstructured":"Hu Z, Li R, Cui X, Chen Z. Albumin-Based Cyanine Crizotinib Conjugate Nanoparticles for NIR-II Imaging-Guided Synergistic Chemophototherapy. ACS Appl Mater Interfaces. 2023;15:33890\u2013902.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4359_CR44","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.7150\/thno.73566","volume":"12","author":"X Wei","year":"2022","unstructured":"Wei X, Song M, Jiang G, Liang M, Chen C, Yang Z, Zou L. Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor. Theranostics. 2022;12:5272\u201398.","journal-title":"Theranostics"},{"key":"4359_CR45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12951-021-00903-7","volume":"19","author":"Z Liu","year":"2021","unstructured":"Liu Z, Xie Z, Li W, Wu X, Jiang X, Li G, Cao L, Zhang D, Wang Q, Xue P, Zhang H. Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges. J Nanobiotechnol. 2021;19:160.","journal-title":"J Nanobiotechnol"},{"key":"4359_CR46","first-page":"e2100876","volume":"8","author":"X Cheng","year":"2021","unstructured":"Cheng X, Gao J, Ding Y, Lu Y, Wei Q, Cui D, Fan J, Li X, Zhu E, Lu Y, et al. Multi-Functional Liposome: A Powerful Theranostic Nano-Platform Enhancing Photodynamic Therapy. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2021;8:e2100876.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"4359_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1186\/s12967-025-06814-7","volume":"23","author":"A Javdani-Mallak","year":"2025","unstructured":"Javdani-Mallak A, Mowla SJ, Alibolandi M. Tumor-derived exosomes and their application in cancer treatment. J Translational Med. 2025;23:751.","journal-title":"J Translational Med"},{"key":"4359_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","volume":"23","author":"L Galluzzi","year":"2024","unstructured":"Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. Targeting immunogenic cell stress and death for cancer therapy. Nat Rev Drug Discovery. 2024;23:445\u201360.","journal-title":"Nat Rev Drug Discovery"},{"key":"4359_CR49","doi-asserted-by":"publisher","first-page":"26666","DOI":"10.1021\/acsnano.4c05773","volume":"18","author":"X Wan","year":"2024","unstructured":"Wan X, Zhang Y, Wan Y, Xiong M, Xie A, Liang Y, Wan H. A Multifunctional Biomimetic Nanoplatform for Dual Tumor Targeting-Assisted Multimodal Therapy of Colon Cancer. ACS Nano. 2024;18:26666\u201389.","journal-title":"ACS Nano"},{"key":"4359_CR50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.semcancer.2022.03.009","volume":"86","author":"X Niu","year":"2022","unstructured":"Niu X, Chen L, Li Y, Hu Z, He F. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC. Sem Cancer Biol. 2022;86:273\u201385.","journal-title":"Sem Cancer Biol"},{"key":"4359_CR51","doi-asserted-by":"publisher","first-page":"122089","DOI":"10.1016\/j.biomaterials.2023.122089","volume":"296","author":"Y Lu","year":"2023","unstructured":"Lu Y, Wang Y, Liu W, Ma H, Yang B, Shao K, Long S, Sun W, Du J, Fan J, et al. Photothermal nano-dot reactivate immune-hot for tumor treatment via reprogramming cancer cells metabolism. Biomaterials. 2023;296:122089.","journal-title":"Biomaterials"},{"key":"4359_CR52","doi-asserted-by":"publisher","first-page":"122182","DOI":"10.1016\/j.biomaterials.2023.122182","volume":"299","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang P, Xie Y, Yang J, Yang Y, Shi L, Wu W, Li Z. Photosensitizers with multiple degradation modes for efficient and postoperatively safe photodynamic therapy. Biomaterials. 2023;299:122182.","journal-title":"Biomaterials"},{"key":"4359_CR53","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang S, Liu X, Bawa-Khalfe T, Lu L-S, Lyu YL, Liu LF, Yeh ETH. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18:1639\u201342.","journal-title":"Nat Med"},{"key":"4359_CR54","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1126\/science.aad0779","volume":"350","author":"E Vacchelli","year":"2015","unstructured":"Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, et al. Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Sci (New York NY). 2015;350:972\u20138.","journal-title":"Sci (New York NY)"},{"key":"4359_CR55","doi-asserted-by":"crossref","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol 2017;17(2):97-111.","DOI":"10.1038\/nri.2016.107"},{"key":"4359_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discovery. 2019;18:197\u2013218.","journal-title":"Nat Rev Drug Discovery"},{"key":"4359_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-024-02191-9","volume":"24","author":"BH Jenkins","year":"2025","unstructured":"Jenkins BH, Tracy I, Rodrigues MFSD, Smith MJL, Martinez BR, Edmond M, Mahadevan S, Rao A, Zong H, Liu K, et al. Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response. Mol Cancer. 2025;24:3.","journal-title":"Mol Cancer"},{"key":"4359_CR58","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger S, Bao R, Gajewski TF. Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature. 2015;523:231\u20135.","journal-title":"Nature"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04359-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:02:10Z","timestamp":1779670930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04359-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4359"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04359-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The mouse squamous cell carcinoma cell line MOC1 Mouse Oral Squamous Cell Carcinoma (OSCC) Cell Line and L-929 mouse fibroblast cell line were sourced from Shandong Key Laboratory of Oral Tissue Regeneration. All animal experiments involved in this study were approved by the Ethics Committee of Shandong University Stomatological Hospital (No.20221138). Female C57 mice (4 - 6 weeks old) were purchased from Vital River Company and housed in the Model Animal Research Center of Shandong University. The study was reported following the ARRIVE guidelines. No human participants were involved; thus, informed consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"456"}}